Entrada Therapeutics, Inc. - COM (TRDA)

Historical Portfolio Holders from Q4 2021 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
29.7M
Holdings value Q2 2024
$423M
Value change Q2 2024
+$52.1M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
82
Number of buys Q2 2024
56
Number of sells Q2 2024
-20
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 9.75K $156K +$156K $16.01 1
2024 Q2 29.7M $423M +$52.1M $14.25 82
2024 Q1 26M $369M -$3.77M $14.17 76
2023 Q4 26.3M $397M +$3.49M $15.09 62
2023 Q3 26M $411M +$4.52M $15.80 55
2023 Q2 25.8M $390M +$13.3M $15.14 56
2023 Q1 24.9M $361M +$2.71M $14.50 53
2022 Q4 24.7M $334M +$2.43M $13.52 46
2022 Q3 24.5M $386M -$2.73M $15.76 33
2022 Q2 24.8M $302M -$12.9M $12.18 35
2022 Q1 25.9M $243M +$2.26M $9.39 48
2021 Q4 24.9M $425M +$414M $17.12 45